KYMR
Kymera Therapeutics Inc
106.00$
-3.5%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 68.0% | 70.4% | 61.9% | 63.6% | 55.0% | 52.2% | 54.6% | 64.4% | 47.9% | 50.0% | 40.6% | 44.8% | |
| 14.7% | 19.1% | 10.8% | 8.2% | 10.7% | 12.3% | 9.8% | 29.7% | 10.2% | 20.5% | 8.6% | 7.6% | |
| 64.8% | 65.1% | 60.0% | 61.7% | 53.1% | 50.0% | 50.4% | 58.8% | 45.9% | 48.7% | 39.0% | 42.0% | |
| 0.7% | 3.3% | 0.2% | 0.2% | 0.1% | 0.1% | 2.2% | 3.5% | – | – | – | 1.2% | |
| – | 0.0% | 0.0% | – | -0.1% | – | – | – | – | – | – | -0.4% | |
| 28.4% | 31.4% | 18.1% | 17.1% | 13.7% | 14.6% | 14.4% | 14.1% | 14.1% | 9.4% | 7.8% | 8.5% | |
| 11.4% | 14.9% | 6.5% | 7.5% | 6.4% | 6.9% | 6.4% | 7.7% | 6.5% | 4.8% | 3.8% | 4.6% | |
| 0.7% | 1.1% | 1.1% | 1.5% | 1.2% | 1.3% | 1.4% | 1.2% | 1.2% | 0.8% | 0.8% | 1.1% | |
| 0.9% | 1.2% | 0.8% | 0.8% | 0.6% | 0.6% | 1.1% | 0.5% | 0.5% | 0.2% | 0.8% | 0.5% | |
| 71.6% | 68.6% | 81.9% | 82.9% | 86.3% | 85.4% | 85.6% | 85.9% | 85.9% | 90.6% | 92.2% | 91.7% | |
| -93.5% | -92.2% | -66.7% | -75.2% | -66.1% | -77.2% | -89.3% | -79.3% | -88.8% | -61.2% | -68.0% | -72.7% | |
| 10.6% | 10.2% | 8.2% | 8.8% | 7.4% | 8.2% | 8.7% | 7.1% | 7.9% | 4.8% | 5.8% | 6.0% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.